U.S. allows increased Vyvanse production to help ADHD drug shortage

The U.S. drug administrator has allowed an increased Vyvanse production of around 24 percent to help with the ADHD drug shortage nationwide. The Drug Enforcement Administration (DEA) greenlighted the spike in production following the Food and Drug Administration (FDA) request, according to a notice first reported by Bloomberg News. FDA’s request came in July. To...